Home Forums Melanoma Diagnosis: Stage IV IPI/PD1 Sequential Studies: Update of locations

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #21556
    Catherine Poole
    Keymaster

    Patients enrolled in the study will be randomized to one of 3 treatment arms. Patients

    randomized to Arm A will receive nivolumab every 2 weeks until disease progression.

    Patients on Arm B will receive nivolumab combined with ipilimumab every 3 weeks for

    4 doses followed by nivolumab alone every 3 weeks until disease progression. Patients

    randomized to Arm C will receive ipilimumab monotherapy every 3 weeks for a total of

    4 doses.

    For study locations near you, please email me as the list is too extensive to post: cpoole@melanomainternational.org. You must be treatment naïve (no previous treatment)

Viewing 1 post (of 1 total)
  • The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.